Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Azacitidine
Medication labelONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or…
Why this: Advisory · dailymed-prescription
ONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.
- generic_name
- azacitidine
- product_names
- azacitidine
- ndc
- 59572-730, 59572-730-14, 59572-730-07, 59572-740, 59572-740-14, 59572-740-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en